Gene: TBC1D2B
Official Full Name: TBC1 domain family member 2Bprovided by HGNC
Gene Summary: Predicted to enable GTPase activator activity. Involved in endocytosis. Located in cytosol and early endosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13555 | TBC1D2B Knockout cell line (HeLa) | Human | TBC1D2B | 1:3~1:6 | Negative | Online Inquiry |
KO13556 | TBC1D2B Knockout cell line (HCT 116) | Human | TBC1D2B | 1:2~1:4 | Negative | Online Inquiry |
KO13557 | TBC1D2B Knockout cell line (HEK293) | Human | TBC1D2B | 1:3~1:6 | Negative | Online Inquiry |
KO13558 | TBC1D2B Knockout cell line (A549) | Human | TBC1D2B | 1:3~1:4 | Negative | Online Inquiry |
TBC1D2B Gene Knockout Cell Lines are genetically engineered cellular models designed to facilitate the study of the TBC1D2B gene and its associated biological pathways. This product features a precise knockout of the TBC1D2B gene, achieved through advanced CRISPR-Cas9 genome editing techniques. These cell lines serve as invaluable tools for researchers interested in elucidating the functional role of TBC1D2B in cellular processes such as autophagy, vesicle trafficking, and metabolic regulation.
The key function of TBC1D2B knockout cell lines lies in their ability to enable direct observation of the phenotypic consequences stemming from the absence of this gene. By utilizing these cell lines, researchers can explore how the knockout impacts cellular morphology, signaling pathways, and protein interactions, thereby providing insights into the gene's contribution to various physiological and pathological conditions. The cell lines are viable for high-throughput assays, making them particularly suitable for drug discovery and therapeutic development.
The scientific importance of TBC1D2B knockout models extends to both research and clinical applications. These models can help elucidate the underlying mechanisms of diseases where TBC1D2B is implicated, such as metabolic disorders and neurodegenerative diseases. Moreover, they provide a platform for screening potential therapeutic agents that may restore normal function or modulate disease pathways.
Compared to traditional knockout models, TBC1D2B Gene Knockout Cell Lines offer several advantages, including faster organismal development and enhanced reproducibility in results. The specificity of CRISPR-Cas9 technology minimizes off-target effects, ensuring that changes observed are solely attributable to the TBC1D2B gene manipulation.
For researchers and clinicians, the value of TBC1D2B Gene Knockout Cell Lines lies in their potential to accelerate discoveries and lead to breakthroughs in our understanding of complex biological systems. Incorporating these models into your research toolbox equips scientists with the capability to make significant advancements in the field of genetics and molecular biology.
Our company, with a proven track record in developing innovative genetic tools, is committed to providing high-quality biological products that enhance research capabilities. We stand at the forefront of the industry, continuously striving to support the scientific community with reliable, cutting-edge resources.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.